advertisement

Topcon

BMJ open ophthalmology 10

Showing records 1 to 10 | Display all abstracts in BMJ open ophthalmology

105867 Impact of cerebral hypoperfusion-reperfusion on optic nerve integrity and visual function in the DBA/2J mouse model of glaucoma
Fraenkl SA
BMJ open ophthalmology 2022; 7:
106950 Efficacy and safety of a fixed combination of 1% brinzolamide and 0.1% brimonidine as treatment for glaucoma: a retrospective study focusing on the number of ingredients
Aoki R; Terao E
BMJ open ophthalmology 2022; 7:
105867 Impact of cerebral hypoperfusion-reperfusion on optic nerve integrity and visual function in the DBA/2J mouse model of glaucoma
Simon Q; Yucel Y
BMJ open ophthalmology 2022; 7:
106950 Efficacy and safety of a fixed combination of 1% brinzolamide and 0.1% brimonidine as treatment for glaucoma: a retrospective study focusing on the number of ingredients
Dote S
BMJ open ophthalmology 2022; 7:
105867 Impact of cerebral hypoperfusion-reperfusion on optic nerve integrity and visual function in the DBA/2J mouse model of glaucoma
Gupta N
BMJ open ophthalmology 2022; 7:
106950 Efficacy and safety of a fixed combination of 1% brinzolamide and 0.1% brimonidine as treatment for glaucoma: a retrospective study focusing on the number of ingredients
Shiraishi M; Oogi S
BMJ open ophthalmology 2022; 7:
105867 Impact of cerebral hypoperfusion-reperfusion on optic nerve integrity and visual function in the DBA/2J mouse model of glaucoma
Wittwer VV; Frueh BE
BMJ open ophthalmology 2022; 7:
106950 Efficacy and safety of a fixed combination of 1% brinzolamide and 0.1% brimonidine as treatment for glaucoma: a retrospective study focusing on the number of ingredients
Ueda K
BMJ open ophthalmology 2022; 7:
105867 Impact of cerebral hypoperfusion-reperfusion on optic nerve integrity and visual function in the DBA/2J mouse model of glaucoma
Tschanz SA
BMJ open ophthalmology 2022; 7:
106950 Efficacy and safety of a fixed combination of 1% brinzolamide and 0.1% brimonidine as treatment for glaucoma: a retrospective study focusing on the number of ingredients
Kimura Y; Nagata Y; Nakakura S
BMJ open ophthalmology 2022; 7:

Issue 23-3

Change Issue


advertisement

Oculus